Influence of bcl-2-related proteins on matrix metalloproteinase expression in a rat glioma cell line

被引:12
|
作者
Oliver, L
Tremblais, K
Guriec, N
Martin, S
Meflah, K
Menanteau, J
Vallette, FM
机构
[1] INSERM, U419, IFR 26, F-44035 Nantes 01, France
[2] CHU Nantes, Clin Neurochirurg, F-44035 Nantes 01, France
关键词
apoptosis; bcl-2 related proteins; gliomas; metalloproteinases;
D O I
10.1006/bbrc.2000.2952
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of bcl-2-related proteins has been shown to be a key element in tumoral malignancy. The degradation of the extracellular matrix (ECM) by specialized matrix metalloproteinases (MMPs) is another major step in tumor invasion and metastasis. We have examined, in a rat glioma cell line A15A5, the effect of the stable transfection of human bcl-2, bax and bcl-xl on MMPs expression. Using a zymographic assay, we found that all transfected cell lines expressed a gelatinase activity which is predominantly associated with MMP-9. In bcl-2 and bcl-xl transfected cells, the transcription of MMP-9 was decreased compared to that of control or bax transfected cells. In addition, in bax transfected A15A5, we observed a down regulation of TIMP-1, the inhibitor of MMP-9. These results suggest that the ratio between MMP-9 and its inhibitor TIMP-1 is tightly controlled in cells overexpressing bcl-2 related proteins (i.e., high ratio in bax transfected A15A5 and low ratio in bcl-2 transfected A15A5). However, MMPs secreted by bcl-2 transfected cells were still capable of hydrolyzing Fast present on human lymphocytes. Our results suggest that the expression of bcl-2 related proteins could participate in the regulation of MMP-9/TIMP-1 in gliomas. (C) 2000 Academic Press.
引用
收藏
页码:411 / 416
页数:6
相关论文
共 50 条
  • [1] Bcl-2-related survival proteins
    Schwartz, P. S.
    Hockenbery, D. M.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (08): : 1250 - 1255
  • [2] Bcl-2-related survival proteins
    P S Schwartz
    D M Hockenbery
    Cell Death & Differentiation, 2006, 13 : 1250 - 1255
  • [3] Bcl-2-related proteins and cancer
    MacCarthy-Morrogh, L
    Mouzakiti, A
    Townsend, P
    Brimmell, M
    Packham, G
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 : 785 - 789
  • [4] Bcl-2-related proteins as drug targets
    O'Neill, JW
    Hockenbery, DM
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (16) : 1553 - 1562
  • [5] Differential expression of Bcl-2-related proteins in differentiating NT2 cells
    Guillemain, I
    Gaboyard, S
    Fontès, G
    Saunier, M
    Privat, A
    Patey, G
    NEUROREPORT, 2000, 11 (07) : 1421 - 1425
  • [6] Targeting Bcl-2-related proteins in cancer therapy
    Manion, MK
    Hockenbery, DM
    CANCER BIOLOGY & THERAPY, 2003, 2 (04) : S105 - S114
  • [7] Regulation of apoptosis: involvement of bcl-2-related proteins
    Motyl, T
    REPRODUCTION NUTRITION DEVELOPMENT, 1999, 39 (01): : 49 - 59
  • [8] Targeted therapy against Bcl-2-related proteins in breast cancer cells
    Manabu Emi
    Ryungsa Kim
    Kazuaki Tanabe
    Yoko Uchida
    Tetsuya Toge
    Breast Cancer Research, 7
  • [9] Execution of Superoxide-Induced Cell Death by the Proapoptotic Bcl-2-Related Proteins Bid and Bak
    Madesh, Muniswamy
    Zong, Wei-Xing
    Hawkins, Brian J.
    Ramasamy, Subbiah
    Venkatachalam, Thilagavathi
    Mukhopadhyay, Partha
    Doonan, Patrick J.
    Irrinki, Krishna M.
    Rajesh, Mohanraj
    Pacher, Pal
    Thompson, Craig B.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (11) : 3099 - 3112
  • [10] The human papillomavirus type 16 E6 oncoprotein alters the expression of Bcl-2-related proteins
    McKalip, A
    Higo, H
    Stumpff, J
    Herman, B
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 195 - 195